Lack of association between EGF 61A>G polymorphism and plasma EGF concentration in the STANISLAS family study [1]

Journal of Investigative Dermatology

Volumn 127, Issue 4, 2007, Pages 969-970

  Berrahmoune, Hind ^a   Herbeth, Bernard ^a   Lamont, John V ^b   Masson, Christine ^a   FitzGerald, Stephen P ^b   Visvikis Siest, Sophie ^a  

^a INSERM   (France)

^b Randox Laboratories Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; EPIDERMAL GROWTH FACTOR; GLUCOSE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CONTROLLED STUDY; FAMILY STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HEREDITY; HUMAN; LETTER; MALE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE COUNT;

ADENINE; EPIDERMAL GROWTH FACTOR; GUANINE; HUMANS; MELANOMA; OSMOLAR CONCENTRATION; POLYMORPHISM, GENETIC; PROGNOSIS; SKIN NEOPLASMS;

EID: 33947277432     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700650     Document Type: Letter

References (10)

1. Amend KL, Elder JT, Tomsho LP, Bonner JD, Johnson TM, Schwartz J et al. (2004) EGF gene polymorphism and the risk of incident primary melanoma. Cancer Res 64:2668-72
2. Berrahmoune H, Lamont JV, Herbeth B, FitzGerald PS, Visvikis-Siest S (2006) Biological determinants of and reference values for plasma interleukin-8, monocyte chemoattractant protein-1, epidermal growth factor, and vascular endothelial growth factor: results from the STANISLAS cohort. Clin Chem 52:504-10
3. Bhowmick DA, Zhuang Z, Wait SD, Weil RJ (2004) A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res 64:1220-3
4. James MR, Hayward NK, Dumenil T, Montgomery GW, Martin NG, Duffy DL (2004) Epidermal growth factor gene (EGF) polymorphism and risk of melanocytic neoplasia. J Invest Dermatol 123:760-2
5. McCarron SL, Bateman AC, Theaker JM, Howell WM (2003) EGF +61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma. Int J Cancer 107:673-5
6. Okamoto I, Roka F, Krögler J, Endler G, Kaufmann S, Tockner S et al. (2006) The EGF A61G polymorphism is associated with disease-free period and survival in malignant melanoma. J Invest Dermatol 29:1175-9
7. Pantsulaia I, Trofimov S, Kobyliansky E, Livshits G (2004) Heritability of circulating growth factors involved in the angiogenesis in healthy human population. Cytokine 27:152-8
8. Shahbazi M, Pravica V, Nasreen N, Fakhoury H, Fryer AA, Strange RC et al. (2002) Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 359:397-401
9. Siest G, Visvikis S, Herbeth B, Gueguen R, Vincent-Viry M, Sass C et al. (1998) Objectives, design and recruitment of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovascular risk: the Stanislas cohort. Clin Chem Lab Med 36:35-42
10. Trégouët DA, Pallaud C, Sass C, Visvikis S, Tiret L (2001) Sample size calculations for classical association and TDT-type methods using family data. Ann Hum Genet 65:293-312